GEN-MKT-18-7897-A
Oct 1, 2019 | Blogs, Software, Technology | 0 comments
As a researcher in a busy lab, the software driving your work is critical to your success, and the timely transition of SCIEX applications to Windows 10 is no exception. In early 2020 Microsoft will be ending Windows 7 support, and we want you to know we are taking every effort to ensure our software applications are up to date in advance of this deadline.
Why Are We Offering Windows 10 Software Application Compatibility?Computer manufacturers like Dell will not be able to ship Windows 7 compatible computers beyond the end of 2018. The reason being, they are having trouble locating components that have Windows 7 compatible drivers. New devices are already being shipped with Windows 10, and we don’t want to hold you back. Therefore, to ensure technological flexibility across your organization, we are offering application support changes now rather than later.
What SCIEX Software Platforms Are Compatible?Migrating to Microsoft’s latest operating system is essential in making sure your laboratory stays relevant and current. This move can present a number of ongoing challenges, including business disruptions or application incompatibilities, however. To address potential issues, SCIEX has released software upgrades, designed to run on Windows 10, for the entire software portfolio, including those solutions that power your mass spectrometry systems, such as Analyst® or SCIEX OS Software. The move to Windows 10 is an excellent first step toward modernizing your workstation software with minimal disruption and maximum benefit, the new SCIEX Alpha Workstation 2020 has just launched.
The Importance of Windows 10 to Your ResearchBy now, your IT team is most likely up to speed on Windows 10. As a reminder, however, Windows 10 was released more than two years ago and has since undergone many updates to improve functionality and security of your PC not to mention data. During this time, there have been some major improvements in the following areas that we feel are noteworthy to your work.
Want to Stay Ahead of the Windows 10 Curve?Get ahead of the January 2020 end-of-support deadline and take advantage of our special upgrade programs as you migrate to Windows 10 >
With this upgrade, you will benefit from a smooth transition to the new operating system and eliminate potential software downtime due to software incompatibility.
In monoclonal antibody (mAb) development, assessment of purity and integrity of the protein in question is critical. CE‑SDS is the gold standard assay and is routinely run from analytical development through QC and lot release. It’s trusted because it consistently delivers quantitative, size‑based insight into purity and fragmentation, and it fits naturally into regulated environments.
In drug discovery and development, Metabolite Identification (Met ID) plays a critical role in understanding biotransformation pathways, ensuring safety, and meeting regulatory requirements. Advanced mass spectrometry techniques have revolutionized this process, particularly through electron-based fragmentation methods such as Electron Activated Dissociation (EAD) and Electron Transfer Dissociation (ETD). While both techniques leverage electron interactions to generate informative fragment ions, they differ significantly in mechanism, performance, and suitability for Met ID workflows.
In analytical laboratories, performance is not optional. Whether supporting regulated pharmaceutical workflows, high-throughput CRO operations, clinical reporting, or food and environmental testing, your mass spectrometry and capillary electrophoresis systems are critical to productivity, compliance, and scientific confidence.
Posted by
You must be logged in to post a comment.
Share this post with your network